Trial Profile
Phase I, Single Centre, Open Label Study to Access The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 After A) a Single Ascending Bolus Dose and B) a Single Ascending Bolus Dose Followed by a Single Infusion Dose in Healthy Japanese Volunteers (Age Range 20-45 Years)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2014
Price :
$35
*
At a glance
- Drugs AZD 3043 (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- Sponsors AstraZeneca
- 14 Nov 2014 New trial record